[Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
D001786:Blood Glucose / Q000378:metabolism*; D050260:Carbohydrate Metabolism; D003920:Diabetes Mellitus / Q000209:etiology*; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood* / Q000494:pharmacology; D005951:Glucose Tolerance Test; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D007329:Insulin Antagonists; D007333:Insulin Resistance; D000078790:Insulin Secretion; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008102:Liver Circulation; D008103:Liver Cirrhosis / Q000097:blood* / Q000150:complications / Q000378:metabolism / Q000503:physiopathology; D008111:Liver Function Tests; D010179:Pancreas / Q000378:metabolism; D014044:Tolbutamide
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007329:Insulin Antagonists; D014044:Tolbutamide
Stoffwechselveränderungen nach Glucose- und Tolbutamidbelastung bei Lebercirrhosen und ihre Rolle in der Pathogenese des hepatogenen Diabetes mellitus.